Skip to content
2000
Volume 21, Issue 4
  • ISSN: 1573-3971
  • E-ISSN: 1875-6360

Abstract

Introduction

Sjögren’s syndrome is a chronic autoimmune disorder that results in dry eyes and mouth. It is rarely associated with cryoglobulinemia, the agglutination of cryoglobulins at cold temperatures that leads to systemic inflammation and organ damage. We have, herein, presented a case of Cryoglobulinemic Vasculitis (CryoVas), which presents as cryoglobulinemic glomerulonephritis and Central Nervous System (CNS) vasculitis and peripheral neuropathy.

Case Report

A 52-year-old woman with a past medical history of Sjögren's syndrome was admitted to the intensive care unit with severe hyponatremia, orthopnea, and progressive lower extremity weakness, and was found to have an intradural extramedullary hematoma with mass effect in the thoracic spine and diffuse hyperintense cord signal abnormality in thoracic spine suggestive of intermixed proteinaceous or hemorrhagic material. Further testing demonstrated that the patient experienced worsening neuropathy, proteinuria, hematuria, declining renal function, and the presence of cryoglobulins in the blood. After a thorough examination and a renal biopsy, the patient was diagnosed with cryoglobulinemic glomerulonephritis and cryoglobulinemic vasculitis of the spine. The patient was treated with rituximab and pulse-dose steroids, with which the patient exhibited improved renal function and resolution of a previously seen intradural hematoma on repeat MRI.

Conclusion

We have, herein, discussed a rare case of cryoglobulinemic vasculitis that has led to a rare CNS manifestation and concomitant cryoglobulinemic glomerulonephritis. This suggests that clinicians should consider cryoglobulinemic vasculitis as the etiology that could manifest with multiorgan involvement, especially in patients with underlying rheumatic diseases.

Loading

Article metrics loading...

/content/journals/crr/10.2174/0115733971311273240824183333
2024-09-11
2025-09-06
Loading full text...

Full text loading...

References

  1. RoccatelloD. SaadounD. Ramos-CasalsM. TzioufasA.G. FervenzaF.C. CacoubP. ZignegoA.L. FerriC. Cryoglobulinaemia.Nat. Rev. Dis. Primers201841112010.1038/s41572‑018‑0009‑430072738
    [Google Scholar]
  2. MuchtarE. MagenH. GertzM.A. How I treat cryoglobulinemia.Blood2017129328929810.1182/blood‑2016‑09‑71977327799164
    [Google Scholar]
  3. KilleenR.B. AwaisM. MikesB.A. Cryoglobulinemia.In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.32491538
    [Google Scholar]
  4. DavuluriS. VaqarS. Cryoglobulinemic vasculitis.In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.32310505
    [Google Scholar]
  5. HaddiyaI. HamzaouiH. AlhamanyZ. Rhou benamar ouzeddoun bayahia BerkchiF. Mixed cryoglobulinemia-associated sjögren’s syndrome leading to spontaneous rupture of the kidney: A case report.Int. Med. Case Rep. J.20169778110.2147/IMCRJ.S6426227042145
    [Google Scholar]
  6. PatrickJ. BabuA. VermaN. An unusual presentation of cryoglobulinemia in a patient with undiagnosed sjögren’s syndrome and treated marginal zone lymphoma.Cureus20221412e3273010.7759/cureus.3273036686139
    [Google Scholar]
  7. LiampasA. ParperisK. ErotocritouM.F. NteverosA. PapadopoulouM. MoschovosC. AkilM. CoaccioliS. HadjigeorgiouG.M. HadjivassiliouM. ZisP. Primary sjögren syndrome-related peripheral neuropathy: A systematic review and meta-analysis.Eur. J. Neurol.202330125526510.1111/ene.1555536086910
    [Google Scholar]
  8. GoulesA.V. TzioufasA.G. Primary sjögren’s syndrome: Clinical phenotypes, outcome and the development of biomarkers.Immunol. Res.201765133134410.1007/s12026‑016‑8844‑427444892
    [Google Scholar]
  9. ShiboskiC.H. ShiboskiS.C. SerorR. CriswellL.A. LabetoulleM. LietmanT.M. RasmussenA. ScofieldH. VitaliC. BowmanS.J. MarietteX. International Sjögren’s syndrome criteria working group. 2016 American college of rheumatology/european league against rheumatism classification criteria for primary Sjögren’s syndrome: A consensus and data-driven methodology involving three international patient cohorts.Arthritis Rheumatol.2017691354510.1002/art.3985927785888
    [Google Scholar]
  10. ChenY.P. ChengH. RuiH.L. DongH.R. Cryoglobulinemic vasculitis and glomerulonephritis: Concerns in clinical practice.Chin. Med. J. (Engl.)2019132141723173210.1097/CM9.000000000000032531283654
    [Google Scholar]
  11. QuartuccioL. BortoluzziA. ScirèC.A. MarangoniA. Del FrateG. TreppoE. CastelnovoL. SaccardoF. ZaniR. CandelaM. FraticelliP. MazzaroC. RenoldiP. ScainiP. FilippiniD.A. VisentiniM. ScarpatoS. GiuggioliD. MasciaM.T. SebastianiM. ZignegoA.L. LaulettaG. FiorilliM. CasatoM. FerriC. PietrograndeM. PioltelliP.E. De VitaS. MontiG. GalliM. Management of mixed cryoglobulinemia with rituximab: Evidence and consensus-based recommendations from the italian study group of cryoglobulinemia (GISC).Clin. Rheumatol.202342235937010.1007/s10067‑022‑06391‑w36169798
    [Google Scholar]
  12. De VitaS. QuartuccioL. IsolaM. MazzaroC. ScainiP. LenziM. CampaniniM. NaclerioC. TavoniA. PietrograndeM. FerriC. MasciaM.T. MasoliniP. ZabottiA. MasetM. RoccatelloD. ZignegoA.L. PioltelliP. GabrielliA. FilippiniD. PerrellaO. MigliaresiS. GalliM. BombardieriS. MontiG. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.Arthritis Rheum.201264384385310.1002/art.3433122147661
    [Google Scholar]
  13. BisognoA Viaro, FedericaV PieroniA RinaldiF CorbettaM, Baracchini ClaudioB Systemic neoplastic cryoglobulinemic vasculitis mimics large vessel occlusion: A case report.The Neurologist202328532632810.1097/NRL.0000000000000489
    [Google Scholar]
/content/journals/crr/10.2174/0115733971311273240824183333
Loading
/content/journals/crr/10.2174/0115733971311273240824183333
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test